Atlas Trials

Metformin for the Minimization of Geographic Atrophy Progression in Patients With AMD

Clinical trial NCT02684578 · COMPLETED

Trial details

NCT number
NCT02684578
Sponsor
University of California, San Francisco
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Age-Related Macular DegenerationMacular Degeneration, Age-RelatedDry Macular DegenerationGeographic Atrophy
Start date
2016-04-01
Primary completion
2022-04-01
Enrollment
66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.